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DOI: http://dx.doi.org/10.1016/j.hemonc.2014.06.001Neuromyelitis optica (NMO), or Devic’s syndrome, is an autoimmune central nervous system demyelinating
disorder primarily affecting the spinal cord and the optic nerves. It is characterized by the presence of NMO
antibodies, alongside clinical and radiological findings. NMO and NMO-spectrum disorders (NMO-SD) have
been reported in autoimmune disorders, and are infrequently described as a paraneoplastic syndrome with can-
cers of lung, breast, and carcinoid tumors of the thyroid. We report a patient who presented with severe vom-
iting, blurring of vision, vertigo, diplopia, left hemiparesis and hemisensory loss and ataxia. She was found to
have a longitudinally-extensive demyelinating lesion extending from the medulla to the upper cervical spinal
cord on MRI. Her gastric endoscopy revealed carcinoid tumor of the stomach, and classic paraneoplastic anti-
bodies in the serum were negative. She had extremely high serum gastrin level and high titer of NMO IgG auto-
antibody. The patient made an excellent recovery with tumor resection and immunotherapy, with both clinical
and radiological improvement. On rare instances, NMO or NMO-SD may present as a paraneoplastic neurolog-
ical syndrome associated with carcinoid tumor of the stomach.
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tumor associated with paraneoplasticNeuromyelitis optica (NMO), or Devic’sdisease, is an autoimmune, inﬂammatorycentral nervous system (CNS) syndrome,
characterized by longitudinally extensive transverse
myelitis, optic neuritis, and the presence of
NMO-IgG autoantibodies.1 The term NMO-spec-
trum disorder (NMO-SD) is used to include lim-
ited forms of NMO. (1) NMO could coexist
with other autoimmune disorders,2–4 and, rarely,
may represent a paraneoplastic phenomenon.5 We
present a case of possible paraneoplastic NMO-
SD in the setting of gastric carcinoid tumor. To
our knowledge, the association of gastric carcinoid
tumors with NMO or NMO-SD has not previ-
ously been reported.CASE REPORT
A 38-year-old woman presented with severe vomiting,
vertigo, blurred vision, diplopia, ataxic gait and left-
sided numbness of two months’ duration. Neurologi-
cal examination demonstrated bilateral paleness of
optic discs, horizontal nystagmus to left, left hemipa-
resis and hemisensory loss, left Babinski’s sign, and
gait ataxia.
MRI brain and spine revealed an enhancing hyper-
intense lesion extending from the medulla to the C2
cord segment (Figure 1A). Visual evoked potentials
displayed bilaterally prolonged P-100. Routine blood
investigations, ESR, autoimmune work up (ANA,
Anti-DNA, SSA, SSB, ANCA, anti-phospholipid
antibodies), viral serologies (HIV, HCV, HBV,dmgr.com
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negative. CSF analysis (cells, protein, sugar, AFB
stain, bacterial cultures), and serum paraneoplastic
antibodies (Hu, CV2, Ri, Ma2, amphiphysin), tested
at Mayo Medical Laboratories, were negative. Serum
B12 was low (83 pmol/L), and NMO-IgG was posi-
tive with high titer.Figure 1A. Pre-treatment sagittal and axial T2-weighted MRI of medull
involving the medulla oblongata and the upper cervical cord.
Hematol Oncol Stem Cell Ther 7(3) Third Quarter 2014 hemoncstem.edmgr.comThe patient had gastric endoscopy for evaluation
of persistent vomiting, which revealed ﬁve gastric
polyps at the antrum, treated with gastric ablation,
and biopsy showed type I gastric carcinoid. Serum
gastrin level was extremely high.
The patient received a ﬁve-day course of intrave-
nous methylprednisolone (1gm/day), followed bya and cervical spine, showing diffuse, ill-defined hyperintense lesion
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intravenous immunoglobulin (2 gm/kg over two
days). This resulted in marked improvement in
her neurological symptoms. She was discharged on
prednisolone, azathioprine, and vitamin B12 replace-
ment. Follow-up MRI showed signiﬁcant regression
of the previously observed lesion (Figure 1B), and
several gastric endoscopies demonstrated no recur-
rence of the tumor. Serum gastrin returned to
normal.Figure 1B. Sagittal and axial T2-weighted MRI obtained after one year of
upper cervical cord.
HemDISCUSSION
NMO is an autoimmune, inﬂammatory, demyelinat-
ing condition of the CNS, characterized by severe
attacks of transverse myelitis and optic neuritis,1 with
at least two of three supportive criteria, consisting of
NMO-IgG seropositivity (directed against aquaporin-
4 water channels), MRI spinal cord lesions extending
more than three vertebral levels, and onset MRI braintherapy, showing resolving lesion at the cervicomedullary junction and
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NMO-SD is a term also used to include limited
forms of NMO, such as isolated single or recurrent
forms of transverse myelitis, unilateral or bilateral
optic neuritis, Asian optic-spinal multiple sclerosis,
and NMO associated with systemic autoimmune dis-
orders. These include systemic lupus erythematosus,2
Sjögren’s syndrome,3 and myasthenia gravis,4 and sig-
nify the coexistence of two autoimmune disorders
rather than a vasculitic complication related to the
systemic disease.1,7 Although rare, NMO may repre-
sent a paraneoplastic phenomenon associated with
various cancers, including thymoma, breast, and
thyroid tumors.5
Carcinoids are neuroendocrine tumors that
originate from the enterochromafﬁn cells of the gas-
trointestinal tract (74%), bronchial system (25%),
and other less frequent organs.8,9 These tumors cause
symptoms by local mass effect, ﬁbrosis, metastasis, or
secretion of bioactive substances, including various
hormones, cytokines and growth factors. As a result,
patients may present with a carcinoid syndrome, caus-
ing cutaneous ﬂushing, diarrhea, abdominal pain, car-
diopulmonary effects, and various endocrinological
syndromes.8
Carcinoid tumors may present with neurological
symptoms, which, in the majority of cases, are due
to endocrine changes, such as myopathy or metasta-
ses. Carcinoid-related paraneoplastic neurological
syndromes have occasionally been described in iso-
lated case reports.9 These include Lambert Eaton
myasthenic syndrome, cerebellar degeneration, limbicHematol Oncol Stem Cell Ther 7(3) Third Quarter 2014 hemoncstem.edmgr.comencephalitis, sensory neuropathy, autonomic dysfunc-
tion, and myelopathy with brain stem encephalitis.9,10
Our patient was diagnosed with NMO-SD, and
was found to have gastric carcinoid tumor. While this
occurrence could be incidental, it may represent a pos-
sible paraneoplastic effect of the cancer. She made an
excellent recovery with treatment of the neurological
condition, as well as tumor ablation, with no recur-
rence on prolonged follow up.
Pittock et al.5 reported several types of neoplasms
in patients with NMO-SD and NMO IgG seroposi-
tivity, including breast carcinoma, thyroid Hürthle
cell, carcinoid, B-cell lymphoma, and pituitary
somatotropinoma. They propose that tumor cells
may express onconeural antigens that can trigger an
aquaporin-4 immune response. Indeed, aquaporin-4
is expressed in many tissues outside the CNS, such
as skeletal muscle, lungs, and stomach parietal cells.5
In addition, several cytokines, especially interleu-
kin 6 (IL-6) are secreted directly by carcinoid tumors.
By enhancing the production of various acute phase
proteins such as serum amyloid, C-reactive protein,
and ﬁbrinogen, IL-6 has an important role in the
development of inﬂammation.10 Similarly, NMO
has been associated with a major activation of
humoral immunity, and the CSF has shown signiﬁ-
cant increases in IL-5, IL-6, and IgM secreting cells.11CONFLICT OF INTEREST
None declared.REFERENCES1. Wingerchuk DM, Lennon VA, Lucchinetti CF,
Pittock SJ, Weinshenker BG. The spectrum of
neuromyelitis optica. Lancet Neurol
2007;6(9):805–15.
2. Gibbs AN, Moroney J, Foley-Nolan D, O'Connell
PG. Neuromyelitis optica (Devic's syndrome) in
systemic lupus erythematosus: a case report. Rheu-
matology (Oxford) 2002;41(4):470–1.
3. Kahlenberg JM. Neuromyelitis optica spectrum
disorder as an initial presentation of primary
Sjçgren's syndrome. Semin Arthritis Rheum
2011;40(4):343–8.
4. Antoine JC, Camdessanch JP, Absi L, Lass-
ablire F, Fasson L. Devic disease and thymoma
with anti-central nervous system and antithymus
antibodies. Neurology 2004;62(6):978–80.5. Pittock SJ, Lennon VA. Aquaporin-4 autoantibod-
ies in a paraneoplastic context. Arch Neurol
2008;65(5):629–32.
6. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchi-
netti CF, Weinshenker BG. Revised diagnostic
criteria for neuromyelitis optica. Neurology
2006;66(10):1485–9.
7. Pittock SJ, Lennon VA, de Seze J, Vermersch P,
Homburger HA, Wingerchuk DM, et al. Neuromye-
litis optica and non organ-specific autoimmunity.
Arch Neurol 2008;65(1):78–83.
8. Ghevariya V, Malieckal A, Ghevariya N, Mazum-
der M, Anand S. Carcinoid tumors of the gastroin-
testinal tract. South Med J 2009;102(10):1032–40.
9. Tschernatsch M, Dierkes C, Gerriets T, Hosch J,
Stolz E, Kaps M, et al. Paraneoplastic neurologicalsyndromes in patients with carcinoid. Eur J Neurol
2008;15(12):1390–4.
10. Kaltsas G, Androulakis II, de Herder WW,
Grossman AB. Paraneoplastic syndromes secondary
to neuroendocrine tumours. Endocr Relat Cancer
2010;17(3):R173–93.
11. Correale J, Fiol M. Activation of humoral
immunity and eosinophils in neuromyelitis optica.
Neurology 2004;63(12):2363–70.119
